These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23220644)

  • 21. Discovery of novel and potent aryl diamines as leukotriene A4 hydrolase inhibitors.
    Khim SK; Bauman J; Evans J; Freeman B; King B; Kirkland T; Kochanny M; Lentz D; Liang A; Mendoza L; Phillips G; Tseng JL; Wei RG; Ye H; Yu L; Parkinson J; Guilford WJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3895-8. PubMed ID: 18590959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Controlling arachidonic acid metabolic network: from single- to multi-target inhibitors of key enzymes].
    Liu Y; Chen Z; Shang EC; Yang K; Wei DG; Zhou L; Jiang XL; He C; Lai LH
    Yao Xue Xue Bao; 2009 Mar; 44(3):231-41. PubMed ID: 19449519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationship studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.
    Penning TD; Chandrakumar NS; Chen BB; Chen HY; Desai BN; Djuric SW; Docter SH; Gasiecki AF; Haack RA; Miyashiro JM; Russell MA; Yu SS; Corley DG; Durley RC; Kilpatrick BF; Parnas BL; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Krivi GG; Villani-Price D; Pyla EY; Smith WG
    J Med Chem; 2000 Feb; 43(4):721-35. PubMed ID: 10691697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.
    Sandanayaka V; Mamat B; Mishra RK; Winger J; Krohn M; Zhou LM; Keyvan M; Enache L; Sullins D; Onua E; Zhang J; Halldorsdottir G; Sigthorsdottir H; Thorlaksdottir A; Sigthorsson G; Thorsteinnsdottir M; Davies DR; Stewart LJ; Zembower DE; Andresson T; Kiselyov AS; Singh J; Gurney ME
    J Med Chem; 2010 Jan; 53(2):573-85. PubMed ID: 19950900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Grice CA; Tays KL; Savall BM; Wei J; Butler CR; Axe FU; Bembenek SD; Fourie AM; Dunford PJ; Lundeen K; Coles F; Xue X; Riley JP; Williams KN; Karlsson L; Edwards JP
    J Med Chem; 2008 Jul; 51(14):4150-69. PubMed ID: 18588282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of predictive quantitative structure-activity relationship model and its application in the discovery of human leukotriene A4 hydrolase inhibitors.
    Thangapandian S; John S; Son M; Arulalapperumal V; Lee KW
    Future Med Chem; 2013 Jan; 5(1):27-40. PubMed ID: 23256811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of selective tight-binding inhibitors of leukotriene A4 hydrolase.
    Yuan W; Munoz B; Wong CH; Haeggström JZ; Wetterholm A; Samuelsson B
    J Med Chem; 1993 Jan; 36(2):211-20. PubMed ID: 8423594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking.
    Audat SA; Al-Shar'i NA; Al-Oudat BA; Bryant-Friedrich A; Bedi MF; Zayed AL; Al-Balas QA
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32580506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase.
    Taylor SJ; Soleymanzadeh F; Eldrup AB; Farrow NA; Muegge I; Kukulka A; Kabcenell AK; De Lombaert S
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5864-8. PubMed ID: 19758802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase.
    Ye B; Bauman J; Chen M; Davey D; Khim SK; King B; Kirkland T; Kochanny M; Liang A; Lentz D; May K; Mendoza L; Phillips G; Selchau V; Schlyer S; Tseng JL; Wei RG; Ye H; Parkinson J; Guilford WJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3891-4. PubMed ID: 18586492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase I: in vitro studies.
    Askonas LJ; Kachur JF; Villani-Price D; Liang CD; Russell MA; Smith WG
    J Pharmacol Exp Ther; 2002 Feb; 300(2):577-82. PubMed ID: 11805219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of alpha lipoic acid on leukotriene A
    Torres MJ; Fierro A; Pessoa-Mahana CD; Romero-Parra J; Cabrera G; Faúndez M
    Eur J Pharmacol; 2017 Mar; 799():41-47. PubMed ID: 28132911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of potent leukotriene A(4) hydrolase inhibitors. Identification of 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid.
    Penning TD; Russell MA; Chen BB; Chen HY; Liang CD; Mahoney MW; Malecha JW; Miyashiro JM; Yu SS; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
    J Med Chem; 2002 Aug; 45(16):3482-90. PubMed ID: 12139459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the active site of leukotriene A4 hydrolase.
    Wetterholm A; Mueller MJ; Blomster M; Samuelsson B; Haeggström JZ
    Adv Exp Med Biol; 1997; 407():1-7. PubMed ID: 9321924
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolase.
    Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Malecha JW; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1137-9. PubMed ID: 12643929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-based alignment in 3D QSAR of 26 indole inhibitors of human pancreatic phospholipase A2.
    Pintore M; Bernard P; Berthon JY; Chrétien JR
    Eur J Med Chem; 2001 Jan; 36(1):21-30. PubMed ID: 11231046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative structure-activity relationship (QSAR) analysis of a series of indole analogues as inhibitor for human group V secretory phospholipase A2.
    OmPraba G; Velmurugan D
    Indian J Biochem Biophys; 2006 Jun; 43(3):154-9. PubMed ID: 16967904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.
    Davies DR; Mamat B; Magnusson OT; Christensen J; Haraldsson MH; Mishra R; Pease B; Hansen E; Singh J; Zembower D; Kim H; Kiselyov AS; Burgin AB; Gurney ME; Stewart LJ
    J Med Chem; 2009 Aug; 52(15):4694-715. PubMed ID: 19618939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution.
    Singh N; Jabeen T; Somvanshi RK; Sharma S; Dey S; Singh TP
    Biochemistry; 2004 Nov; 43(46):14577-83. PubMed ID: 15544328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent and selective inhibitors of leukotriene A4 hydrolase: effects on purified enzyme and human polymorphonuclear leukocytes.
    Wetterholm A; Haeggström JZ; Samuelsson B; Yuan W; Munoz B; Wong CH
    J Pharmacol Exp Ther; 1995 Oct; 275(1):31-7. PubMed ID: 7562564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.